Domestic pharmaceutical companies have recently been continuing to do R&D (Research and Development)
in order to develop global drugs moving away from the focus on generic drugs.
When viewing how pharmaceutical companies develop new drugs, candidate materials should be sought and
clinical trial phases 1 to 3 should be passed through after undergoing pre-clinical trials – animal testing.
However, development of new pharmaceuticals ceases intermittently, as drugs that have worked in the
pre-clinical trials fail to have an effect on the human clinical trials. It is just as important how effective drugs could
be in humans.
If the effects of drugs can be identified at the cellular level of human tissues, costs and time for clinical trials can
be saved. Hence, at the pre-clinical stage or before clinical trial, active researches into the effects of drugs using
tissue chips or organoids have lately been proceeding in the global markets including Europe.
A tissue chip or organoid is a three-dimensional structure that has similar structure or functions to miniature body
parts made from stem cells in order to ensure a minimum function.
In Korea, however, tissue chips and organoids have never been applied in actual clinical trials.
Even domestic pharmaceutical companies urgently need to introduce the platform technology for new drug
development so as to stand as a global pharmaceutical company.
At the upcoming 11th Seoul International New Pharmaceuticals Forum, we will find out how tissue chips and
organoids will be applied in the clinical trials and help develop new drugs.
Prof. Christopher Hughes from University of California, Irvine, an expert of tissue chips, will give a keynote speech.
Prof. Koo, Bon Kyoung from IMBA, Austria and Dr. Jeong, Ga Young from GSK will give a lecture on the organoid
field and the real applications of organoids respectively.
Title : The 11th Seoul International New Pharmaceuticals Forum
Theme : Paradigm Shift in the Development of New Drugs, Tissue Chips and Organoids
Date : June 20th, 2019(Thu) / 09:00 ~ 14:50
Venue : Park Ballroom, Conrad Hotel, Seoul(5F)
Host : The Financial News, Korea Research Institute of Chemical Technology
Supporters : Ministry of Health and Welfare, Ministry of Science and ICT,
Ministry of Trade, Industry and Energy,
National Institute of Food and Drug Safety Evaluation,
Korea Pharmaceutical and Bio-Pharma Manufacturers Association,
Korea Biotechnology Industry Organization,
Korea Research-based Pharmaceutical Industry Association
Inquiry : Seoul International New Pharmaceuticals Forum Bureau
Tel. 02-6965-0013 / Mail. firstname.lastname@example.org